BSECompany Update3d ago · 4 Aug 2026, 05:43 pm
Please find attached Statement of Deviation and Variation in utilization of funds raised through preferencial issue for the quarter ended June 30, 2026
Thirumalai Chemicals Ltd · 500412
✦ AI SummaryResults
Thirumalai Chemicals Ltd has submitted a statement of deviation or variation in the utilization of funds raised through a preferential issue for the quarter ended June 30, 2026. The company has not deviated from the approved objects of the funds, and the audit committee has reviewed the statement. The funds were raised for investment in TCL global BV for onward investment into TCL Specialties LLC in the United States, general corporate purposes, and issue expenses.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Thirumalai Chemicals Ltd - 500412 - Compliances - Statement Of Deviation & Variation Under Regulation 32 Of SEBI (LODR)
Attachments (1)
📄pdf
Download →
46a4ded3-340c-4b5c-9e27-f7598dd736a1.pdf
View document text
Registered Office:
“THIRUMALAI HOUSE”,
Plot No. 101-102, Road No. 29,
Sion (East), Mumbai – 400 022, India
PHONE: +91 – 22– 43686200
FAX +91 – 22 – 24011699
E- MAIL: thirumalai@thirumalaichemicals.com
Website: www.thirumalaichemicals.com
(AN ISO 9001, 14001, 50001/ HACCP & FSSC 22000 CERTIFIED COMPANY)
CIN: L24100MH1972PLC016149
TCL/SE026/2026-27
August 04, 2026
The National Stock Exchange of India Limited BSE Limited
Listing Department Department of Corporate Services
Exchange Plaza, Bandra Kurla Complex Floor 25, Phiroze Jeejeebhoy Towers
Bandra (East) Dalal Street
Mumbai 400 051 Mumbai 400 001
Scrip code: TIRUMALCHM Scrip code: 500412
Dear Sir/ Madam,
Sub.: Statement of Deviation or Variation in utilization of funds raised under
Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulation,
2015 for the Quarter ended June 30, 2026
Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, as amended, please find enclosed herewith the Statement of Deviation or
variation in utilization of funds raised through Preferential issue by the Company, for the
quarter ended June 30, 2026, reviewed by the Audit Committee at its meeting held on August
03, 2026.
This is for your information and records.
Thanking you,
For Thirumalai Chemicals Limited
Aditya Sharma
Company Secretary & Compliance officer
Statement on Deviation or Va1iation for Preferential Issue
Name of listed entity Thirumalai Chemicals Limited
Mode of Fund Raising Preferential Issuance
Date of Raising Funds December 18, 2025
Amount Raised Rs. 5613.99 Lakhs
Report filed for Quarter ended June 30, 2026
Monitoring Agency NA
Monitoring Agency Name, if applicable NA
Is there a Deviation / Variation in use of funds No
raised
If yes, whether the same is pursuant to change Not Applicable
in terms of a contract or objects, which was
approved by the shareholders
If Yes, Date of shareholder Approval Not Applicable
Explanation for the Deviation / Variation Not Applicable
Comments of the Audit Committee after
review Nil
Comments of the auditors, if any Nil
Objects for which funds have been raised and where there has been a deviation, in the
following table:
Amount
Deviati
Variatio
n for
quarter
Modifie Original Funds to
d Allocatio Modified Utilized applica
Object, n (Rs. In Allocation (Rs. In ble Remarks, if
Original Object if Any lakhs) (Rs. In lakhs) lakhs) object any
Investment in TCL global
BV for onward
investment eventually
into TCL Specialties LLC
in the United States of
America to finance
capital expenditure NIL 3599.00 3584.62 3584.62 NIL NIL
General Corporate
Purposes NIL 2000.00 2,013.57 2,012.59 NIL NIL
Issue Expenses NIL 15 15.8 15.8 NIL NIL
• Out of the funds received, Rs. 0.98 Lakhs is still lying as a balance in the Share
Application Account and will be utilised for General Corporate Purposes.
For Thirumalai Chemicals Limited
Ramya Bharathram
Managing Director and CFO